Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Liss

Showing results (251-260 of 256) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 256 results.
Cell Reports. Medicine|January 20, 2024
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomasShiqin Liu, Timothy Chai, Fernando Garcia-Marques, et al.
The Journal of Urology|April 8, 2015
Gleason 6 Prostate Cancer: Translating Biology into Population HealthScott E Eggener, Ketan Badani, Daniel A Barocas, et al.
The Journal of Urology|June 24, 2025
Reply by AuthorsMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology|May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive ValueMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 17, 2026
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancerDeondre D Do, Mariluz Rojo Domingo, Christopher C Conlin, et al.
Science (New York, N.Y.)|January 15, 1982
Hayflick-NIH SettlementB L Strehler, S Abraham, K Bayreuther, et al.
Pageof 26

Showing results (251-260 of 256) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 256 results.
Cell Reports. Medicine|January 20, 2024
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomasShiqin Liu, Timothy Chai, Fernando Garcia-Marques, et al.
The Journal of Urology|April 8, 2015
Gleason 6 Prostate Cancer: Translating Biology into Population HealthScott E Eggener, Ketan Badani, Daniel A Barocas, et al.
The Journal of Urology|June 24, 2025
Reply by AuthorsMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
The Journal of Urology|May 16, 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive ValueMariluz Rojo Domingo, Deondre D Do, Christopher C Conlin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 17, 2026
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancerDeondre D Do, Mariluz Rojo Domingo, Christopher C Conlin, et al.
Science (New York, N.Y.)|January 15, 1982
Hayflick-NIH SettlementB L Strehler, S Abraham, K Bayreuther, et al.
Pageof 26